2011
DOI: 10.1002/anie.201007051
|View full text |Cite
|
Sign up to set email alerts
|

Sitagliptin Manufacture: A Compelling Tale of Green Chemistry, Process Intensification, and Industrial Asymmetric Catalysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
70
0
3

Year Published

2011
2011
2021
2021

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 188 publications
(73 citation statements)
references
References 12 publications
0
70
0
3
Order By: Relevance
“…Such a large value makes it economically impractical for a company to bring this process to a commercial scale. Consequently, researchers at Merck began to work with scientists at Solvias and Codexis (companies specializing in homogeneous catalysis and biocatalysis respectively) in order to develop a more efficient process [41]. The 2006 secondgeneration synthesis (an asymmetric hydrogenation route) succeeded in lowering the E factor to 67 (65 kg organic waste and 2 kg aqueous waste) [47].…”
Section: Comentioning
confidence: 99%
See 3 more Smart Citations
“…Such a large value makes it economically impractical for a company to bring this process to a commercial scale. Consequently, researchers at Merck began to work with scientists at Solvias and Codexis (companies specializing in homogeneous catalysis and biocatalysis respectively) in order to develop a more efficient process [41]. The 2006 secondgeneration synthesis (an asymmetric hydrogenation route) succeeded in lowering the E factor to 67 (65 kg organic waste and 2 kg aqueous waste) [47].…”
Section: Comentioning
confidence: 99%
“…A well-established example of this approach is the redesigned synthesis of sitagliptin phosphate ( Fig. 1.3) [41]. Sitagliptin is the active ingredient in Januvia ® , a drug marketed by Merck for the treatment of type II diabetes [42].…”
Section: Merck's Synthesis Of Januvia: Highlights and Global Efficiencymentioning
confidence: 99%
See 2 more Smart Citations
“…To date, ω-transaminase (ω-TA) is the only naturally occurring enzyme that can mediate the asymmetric reductive amination of ketones, which renders the enzyme attractive for the industrial production of chiral amines. 3,4) One of the challenges for the ω-TA-catalyzed amination of ketones is unfavorable reaction equilibrium. 5,6) For example, the equilibrium constant (K eq ) of the transamination between acetophenone and alanine was determined to be 8.8 × 10 −4 .…”
mentioning
confidence: 99%